Iron oxide nanoparticles augment the intercellular mitochondrial transfer-mediated therapy.
Ontology highlight
ABSTRACT: The transfer of mitochondria between cells has recently been revealed as a spontaneous way to protect the injured cells. However, the utilization of this natural transfer process for disease treatment is so far limited by its unsatisfactory transfer efficiency and selectivity. Here, we demonstrate that iron oxide nanoparticles (IONPs) can augment the intercellular mitochondrial transfer from human mesenchymal stem cells (hMSCs) selectively to diseased cells, owing to the enhanced formation of connexin 43–containing gap junctional channels triggered by ionized IONPs. In a mouse model of pulmonary fibrosis, the IONP-engineered hMSCs achieve a remarkable mitigation of fibrotic progression because of the promoted intercellular mitochondrial transfer, with no serious safety issues identified. T
SUBMITTER: Huang T
PROVIDER: S-EPMC8480934 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA